Unitary pharmaceutical dosage form
US9018192B2 · kind B2 · utility
7Cited by
77References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 10, 2013 |
| Grant date | Apr 28, 2015 |
| Priority date | — |
| Expiry date | Oct 10, 2033 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P31/18
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
In accordance with this invention a novel pharmaceutical product containing efavirenz, emtricitabine and tenofovir DF are provided as a multicomponent unitary oral dosage form, component 1 comprising tenofovir DF (and, optionally, emtricitabine) and component 2 comprising efavirenz, wherein components 1 and 2 are in a stabilizing configuration. In preferred embodiments component 1 is made by dry granulation.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.